Matthew Hsu

AnaptysBio

Poster(s):

• Th142 - Discovery of a Novel High Affinity Anti-human CD122 Antagonist Monoclonal Antibody (ANA033) That Abrogates IL-2 and IL-15 Signaling for the Treatment of T Cell-mediated Inflammatory and Autoimmune Diseases
  Thursday, June 22, 2023

  6:00 PM – 7:45 PM